Who Owns Evaxion A/S Stock?
NASDAQ: EVAXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 9.31%
- Held by insiders
- 16.15%
- Institutional holders
- 20
- Institutions 9.3%
- Insiders 16.1%
- Public and other 74.5%
Who owns Evaxion A/S stock?
Institutional investors own about 9.3% of Evaxion A/S's shares, spread across 20 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 16.15% of EVAX.
The largest institutional holders are Merck & Co., Inc. (13.46%), Ikarian Capital, LLC (0.83%) and Rathbones Group PLC (0.51%). Together, the top 10 institutions control 16.8% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their EVAX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of EVAX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Merck & Co., Inc. | 1.21M | 13.46% | 0.0% |
| Ikarian Capital, LLC | 74.70K | 0.83% | 0.0% |
| Rathbones Group PLC | 45.72K | 0.51% | 0.0% |
| Citadel Advisors Llc | 36.58K | 0.41% | +105.8% |
| Renaissance Technologies, LLC | 33.80K | 0.37% | -13.8% |
| Annis Gardner Whiting Capital Advisors, LLC | 30.00K | 0.33% | 0.0% |
| J. Safra Sarasin Holding AG | 22.90K | 0.25% | +100.0% |
| Rhumbline Advisers | 21.85K | 0.24% | +0.9% |
| Jane Street Group, LLC | 20.58K | 0.23% | +100.0% |
| Boothbay Fund Management, LLC | 18.43K | 0.20% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of EVAX
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 621 | 0.01% |
Frequently asked questions
Who is the largest shareholder of Evaxion A/S?
Merck & Co., Inc. is the largest institutional shareholder of EVAX, owning 13.46% of shares outstanding (1.21M shares) as of its latest 13F filing.
What percentage of Evaxion A/S is owned by institutions?
Institutions own about 9.3% of EVAX shares and 11.1% of the public float.
How much of Evaxion A/S do insiders own?
Insiders, such as officers and directors, own about 16.15% of EVAX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.